Published in Am J Physiol Cell Physiol on October 15, 2014
Mesenchymal Stromal Cells in Animal Bleomycin Pulmonary Fibrosis Models: A Systematic Review. Stem Cells Transl Med (2015) 0.97
Shared gene expression patterns in mesenchymal progenitors derived from lung and epidermis in pulmonary arterial hypertension: identifying key pathways in pulmonary vascular disease. Pulm Circ (2016) 0.79
Mesenchymal Stem Cell Therapy Protects Lungs from Radiation-Induced Endothelial Cell Loss by Restoring Superoxide Dismutase 1 Expression. Antioxid Redox Signal (2016) 0.79
Lung Pericytes and Resident Fibroblasts: Busy Multitaskers. Am J Pathol (2016) 0.79
Disruption of lineage specification in adult pulmonary mesenchymal progenitor cells promotes microvascular dysfunction. J Clin Invest (2017) 0.77
Antagonism of the thromboxane-prostanoid receptor is cardioprotective against right ventricular pressure overload. Pulm Circ (2016) 0.76
Purinergic signaling in scarring. FASEB J (2015) 0.76
Stem Cells in Lung Injury and Repair. Am J Pathol (2016) 0.75
The Role of Lymphocytes in Radiotherapy-Induced Adverse Late Effects in the Lung. Front Immunol (2016) 0.75
From Here to There, Progenitor Cells and Stem Cells Are Everywhere in Lung Vascular Remodeling. Front Pediatr (2016) 0.75
A high-yield isolation and enrichment strategy for human lung microvascular endothelial cells. Pulm Circ (2017) 0.75
Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy (2006) 37.55
The basics of epithelial-mesenchymal transition. J Clin Invest (2009) 32.82
A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell (2008) 18.18
Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest (2003) 12.56
The ABC transporter Bcrp1/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med (2001) 11.94
The myofibroblast: one function, multiple origins. Am J Pathol (2007) 8.64
Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. Development (1999) 7.12
Pericytes: developmental, physiological, and pathological perspectives, problems, and promises. Dev Cell (2011) 6.12
PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate. J Cell Biol (1998) 5.21
Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. Am J Pathol (2008) 5.06
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. Am J Pathol (2002) 5.04
A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells. Nat Cell Biol (2006) 4.55
Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A (2011) 3.82
The myofibroblast in pulmonary fibrosis. Chest (2002) 3.46
Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs. Nat Med (2013) 3.35
The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis? Int J Biochem Cell Biol (2007) 3.33
IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med (2003) 3.29
Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest (2007) 3.16
Regulation of PDGF and its receptors in fibrotic diseases. Cytokine Growth Factor Rev (2004) 3.14
Activation of canonical Wnt signalling is required for TGF-β-mediated fibrosis. Nat Commun (2012) 2.65
Epithelial origin of myofibroblasts during fibrosis in the lung. Proc Am Thorac Soc (2006) 2.61
Mesenchymal stem cells in acute kidney injury. Annu Rev Med (2008) 2.33
Inhibition of platelet-derived growth factor signaling attenuates pulmonary fibrosis. J Exp Med (2005) 2.25
Extracellular superoxide dismutase deficiency exacerbates pressure overload-induced left ventricular hypertrophy and dysfunction. Hypertension (2007) 2.20
Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol (2011) 2.15
Host responses in tissue repair and fibrosis. Annu Rev Pathol (2012) 2.10
Role of the extracellular matrix in regulating stem cell fate. Nat Rev Mol Cell Biol (2013) 2.09
Epithelial-mesenchymal interactions in pulmonary fibrosis. Annu Rev Physiol (2011) 1.97
Side population cells and Bcrp1 expression in lung. Am J Physiol Lung Cell Mol Physiol (2003) 1.90
Fgf10 expression identifies parabronchial smooth muscle cell progenitors and is required for their entry into the smooth muscle cell lineage. Development (2005) 1.88
Heterogeneity of microvascular pericytes for smooth muscle type alpha-actin. J Cell Biol (1991) 1.88
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest (2007) 1.87
An FGF-WNT gene regulatory network controls lung mesenchyme development. Dev Biol (2008) 1.78
Role of the pericyte in wound healing. An ultrastructural study. Exp Mol Pathol (1970) 1.78
Pericyte-specific expression of Rgs5: implications for PDGF and EDG receptor signaling during vascular maturation. FASEB J (2003) 1.76
The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol (2009) 1.76
Fgf10 dosage is critical for the amplification of epithelial cell progenitors and for the formation of multiple mesenchymal lineages during lung development. Dev Biol (2007) 1.74
Transcription profiling of platelet-derived growth factor-B-deficient mouse embryos identifies RGS5 as a novel marker for pericytes and vascular smooth muscle cells. Am J Pathol (2003) 1.74
Epithelial mesenchymal transition is a characteristic of hyperplasias and tumors in mammary gland from MMTV-Cripto-1 transgenic mice. J Cell Physiol (2004) 1.69
The three R's of lung health and disease: repair, remodeling, and regeneration. J Clin Invest (2011) 1.68
Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med (2003) 1.67
Inhibition of placental growth factor activity reduces the severity of fibrosis, inflammation, and portal hypertension in cirrhotic mice. Hepatology (2011) 1.65
Mesenchyme specifies epithelial differentiation in reciprocal recombinants of embryonic lung and trachea. Dev Dyn (1998) 1.65
Formation and differentiation of multiple mesenchymal lineages during lung development is regulated by beta-catenin signaling. PLoS One (2008) 1.63
Epithelial-to-mesenchymal and endothelial-to-mesenchymal transition: from cardiovascular development to disease. Circulation (2012) 1.53
Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol (2013) 1.51
Isolation of an adult mouse lung mesenchymal progenitor cell population. Am J Respir Cell Mol Biol (2007) 1.45
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2012) 1.44
Capillary regeneration in scleroderma: stem cell therapy reverses phenotype? PLoS One (2008) 1.42
Parabronchial smooth muscle constitutes an airway epithelial stem cell niche in the mouse lung after injury. J Clin Invest (2011) 1.38
Fibroblasts share mesenchymal phenotypes with stem cells, but lack their differentiation and colony-forming potential. Biol Cell (2011) 1.31
Periostin, a matricellular protein, plays a role in the induction of chemokines in pulmonary fibrosis. Am J Respir Cell Mol Biol (2012) 1.24
Approaching the degradome in idiopathic pulmonary fibrosis. Int J Biochem Cell Biol (2007) 1.24
Connexins: gaps in our knowledge of vascular function. Physiology (Bethesda) (2004) 1.19
Rgs5 targeting leads to chronic low blood pressure and a lean body habitus. Mol Cell Biol (2008) 1.19
Lung cells from neonates show a mesenchymal stem cell phenotype. Am J Respir Crit Care Med (2007) 1.18
Adult lung side population cells have mesenchymal stem cell potential. Cytotherapy (2008) 1.17
Mesenchymal cell survival in airway and interstitial pulmonary fibrosis. Fibrogenesis Tissue Repair (2010) 1.17
Levels of mesenchymal FGFR2 signaling modulate smooth muscle progenitor cell commitment in the lung. Dev Biol (2006) 1.15
Generation and characterization of rgs5 mutant mice. Mol Cell Biol (2008) 1.13
The pathology of bleomycin-induced fibrosis is associated with loss of resident lung mesenchymal stem cells that regulate effector T-cell proliferation. Stem Cells (2011) 1.12
Genesis of the myofibroblast in lung injury and fibrosis. Proc Am Thorac Soc (2012) 1.11
Dysfunctional resident lung mesenchymal stem cells contribute to pulmonary microvascular remodeling. Pulm Circ (2013) 1.09
Transforming growth factor-beta induction of smooth muscle cell phenotpye requires transcriptional and post-transcriptional control of serum response factor. J Biol Chem (2001) 1.08
Pericyte requirement for anti-leak action of angiopoietin-1 and vascular remodeling in sustained inflammation. Am J Pathol (2011) 1.08
Prospective isolation of murine hematopoietic stem cells by expression of an Abcg2/GFP allele. Stem Cells (2006) 1.07
Pericytes promote selective vessel regression to regulate vascular patterning. Blood (2012) 1.07
The pathogenesis of COPD and IPF: distinct horns of the same devil? Respir Res (2012) 1.06
Lung extracellular superoxide dismutase overexpression lessens bleomycin-induced pulmonary hypertension and vascular remodeling. Am J Respir Cell Mol Biol (2010) 1.05
Pivotal role of pericytes in kidney fibrosis. Clin Exp Pharmacol Physiol (2011) 1.05
Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung. Exp Hematol (2007) 1.04
Microvascular remodeling and wound healing: a role for pericytes. Int J Biochem Cell Biol (2012) 1.01
Targeting pericyte differentiation as a strategy to modulate kidney fibrosis in diabetic nephropathy. Semin Nephrol (2012) 1.00
Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension. Circulation (2014) 0.99
Multipotent mesenchymal progenitor cells are present in endarterectomized tissues from patients with chronic thromboembolic pulmonary hypertension. Am J Physiol Cell Physiol (2010) 0.98
Secretoglobin 3A2 suppresses bleomycin-induced pulmonary fibrosis by transforming growth factor beta signaling down-regulation. J Biol Chem (2011) 0.97
Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis. Kidney Int (2013) 0.96
Abcg2 expression marks tissue-specific stem cells in multiple organs in a mouse progeny tracking model. Stem Cells (2012) 0.95
RGS5 expression is a quantitative measure of pericyte coverage of blood vessels. Angiogenesis (2007) 0.95
Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification. Am J Physiol Lung Cell Mol Physiol (2007) 0.95
Is scleroderma a vasculopathy? Curr Rheumatol Rep (2009) 0.94
Abnormal pericyte recruitment as a cause for pulmonary hypertension in Adams-Oliver syndrome. Am J Med Genet A (2004) 0.93
Immunohistochemical study of NG2 chondroitin sulfate proteoglycan expression in the small and large intestines. Histochem Cell Biol (2006) 0.92
α-Catulin downregulates E-cadherin and promotes melanoma progression and invasion. Int J Cancer (2012) 0.92
Pericyte-endothelial crosstalk: implications and opportunities for advanced cellular therapies. Transl Res (2014) 0.90
Interleukin-1beta induces increased transcriptional activation of the transforming growth factor-beta-activating integrin subunit beta8 through altering chromatin architecture. J Biol Chem (2011) 0.90
Six1 transcription factor is critical for coordination of epithelial, mesenchymal and vascular morphogenesis in the mammalian lung. Dev Biol (2011) 0.89
Molecular basis of interaction between NG2 proteoglycan and galectin-3. J Cell Biochem (2006) 0.89
Lung bone marrow-derived hematopoietic progenitor cells enhance pulmonary fibrosis. Am J Respir Crit Care Med (2013) 0.87
Mice deficient in galectin-1 exhibit attenuated physiological responses to chronic hypoxia-induced pulmonary hypertension. Am J Physiol Lung Cell Mol Physiol (2006) 0.83
S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis. Respir Med (2011) 0.83
Stem cells in airway smooth muscle: state of the art. Proc Am Thorac Soc (2008) 0.83
Galectin-3-binding protein: a serological and histological assessment in accordance with hepatitis C-related liver fibrosis. Eur J Gastroenterol Hepatol (2010) 0.82
Mesenchymal stem cells in chronic lung disease: culprit or savior? Am J Physiol Lung Cell Mol Physiol (2010) 0.81
Topographical specificity in isolated retinal capillary basement membranes: a high-resolution scanning electron microscope analysis. Microvasc Res (1988) 0.79
Regulation of pulmonary inflammation by mesenchymal cells. Pulm Pharmacol Ther (2014) 0.79
Pulmonary arteriole gene expression signature in idiopathic pulmonary fibrosis. Eur Respir J (2013) 0.79
Fenestrated subendothelial basement membranes in human retinal capillaries. Invest Ophthalmol Vis Sci (1989) 0.78
Bone Marrow-Derived Cells in the Pathogenesis of Lung Fibrosis. Curr Respir Med Rev (1) 0.76